These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4195220)

  • 1. Combined treatment of parkinsonism with L-dopa and amantadine.
    Hunter KR; Stern GM; Laurence DR; Armitage P
    Lancet; 1970 Sep; 2(7672):566. PubMed ID: 4195220
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined treatment of parkinsonism with L-dopa and amantadine.
    Godwin-Austen RB; Frears CC; Bergmann S; Parkes JD; Knill-Jones RP
    Lancet; 1970 Aug; 2(7669):383-5. PubMed ID: 4194690
    [No Abstract]   [Full Text] [Related]  

  • 3. L-dopa and amantadine in the therapy of parkinsonism.
    Weeth JB; Shealy CN; Mercier DA
    Wis Med J; 1969 Nov; 68(11):325-8. PubMed ID: 4901055
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined L-dopa and amantadine in Parkinsonism.
    Pollock M; Jorgensen PB
    Aust N Z J Med; 1972 Aug; 2(3):252-5. PubMed ID: 4564049
    [No Abstract]   [Full Text] [Related]  

  • 5. [Principles for amantadine therapy in parkinsonism].
    Gilland O
    Lakartidningen; 1972 Nov; 69(46):5343-5. PubMed ID: 4650743
    [No Abstract]   [Full Text] [Related]  

  • 6. Interactions of L-dopa and amantadine in patients with Parkinsonism.
    Cox B; Danta G; Schnieden H; Yuill GM
    J Neurol Neurosurg Psychiatry; 1973 Jun; 36(3):354-61. PubMed ID: 4714097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of amandine to patients on optimum L-dopa dosage.
    Fehling C
    Acta Neurol Scand Suppl; 1972; 51():119-20. PubMed ID: 4514335
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined treatment of Parkinson's disease with amantadine and L-dopa.
    Scotti G
    Lancet; 1970 Jun; 1(7661):1394-5. PubMed ID: 4194144
    [No Abstract]   [Full Text] [Related]  

  • 9. Amantadine versus L-2 dopa and amatadine plus L-dopa.
    Fieschi C; Nardini M; Casacchia M; Tedone ME; Reitano M; Robotti E
    Lancet; 1970 Jul; 2(7664):154-5. PubMed ID: 4194541
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical results of the intravenous administration of amantadine in patients with parkinsonism].
    Caliri F; Di Rosa AE; Meduri M; Megna G; Musolino R; Scuderi D
    Minerva Med; 1971 Oct; 62(82):3994-6. PubMed ID: 5125062
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of parkinsonism by amantadine and levodopa.
    Mawdsley C; Williams IR; Pullar IA; Davidson DL; Kinloch NE
    Clin Pharmacol Ther; 1972; 13(4):575-83. PubMed ID: 4557584
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of Parkinson's syndrome with L-dopa associated with diphenhydramine hydrochloride and amantadine hydrochloride].
    Scotti G
    Sist Nerv; 1970; 22(2):144-52. PubMed ID: 5504553
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of Parkinson's disease with amantadine and L-Dopa.
    Rinne UK; Sonninen V; Siirtola T
    Eur Neurol; 1972; 7(4):228-40. PubMed ID: 4556618
    [No Abstract]   [Full Text] [Related]  

  • 14. Refinement in the measurement of treatment response with combined L-dopa and amantadine in Parkinsonism.
    Kravitz EA; Hollmann TD
    J Chronic Dis; 1974 Dec; 27(11-12):563-72. PubMed ID: 4612055
    [No Abstract]   [Full Text] [Related]  

  • 15. Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease.
    Schwab RS; England AC
    Trans Am Neurol Assoc; 1969; 94():85-90. PubMed ID: 4907453
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical evaluation of amantadine therapy for parkinsonism and the side effects--in cases of thalamic surgery and L-dopa therapy.
    Matsumoto K; Omoto T; Beck H
    Folia Psychiatr Neurol Jpn; 1974 Jan; 28(1):1-10. PubMed ID: 4406943
    [No Abstract]   [Full Text] [Related]  

  • 17. Experimental treatment of parkinsonism with L-Dopa.
    Cotzias GC; Papavasiliou PS; Gellene R
    Neurology; 1968 Mar; 18(3):276-7. PubMed ID: 4869717
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma concentrations of L-dopa and 3-methoxydopa and improvement in clinical ratings and motor performance in patients with Parkinsonism treated with L-dopa alone or in combination with amantadine.
    Pilling JB; Baker J; Iversen LL; Iversen SD; Robbins T
    J Neurol Neurosurg Psychiatry; 1975 Feb; 38(2):129-35. PubMed ID: 1097598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of amantadine, placebo, and levodopa in Parkinson's disease.
    Bauer RB; McHenry JT
    Neurology; 1974 Aug; 24(8):715-20. PubMed ID: 4858417
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of Parkinsonism with L-dopa and amantadine.
    Millac P; Hasan I; Espir ML; Slyfield DG
    Lancet; 1970 Oct; 2(7675):720. PubMed ID: 4195954
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.